{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:23:42Z","timestamp":1787869422160,"version":"build-2784847793"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>MtDNA 3243 A\u2009&gt;\u2009G mutation leads to mitochondrial myopathies with predominant hyperlactatemia. Given the ubiquitous nature of mitochondria, cellular dysfunction can also appear in tissues with high metabolic turnover; thus, there can be cardiac, digestive, ophthalmologic, and kidney complications. MtDNA 3243 A\u2009&gt;\u2009G mutation has been shown to be with renal involvement in the previous cases of which are FSGS and tubularinterstitial nephritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of patient who had the mitochondrial myopathy with mitochondrial DNA (mtDNA) 3243 A\u2009&gt;\u2009G mutation diagnosed membranous nephropathy by kidney biopsy, which was never reported before. Our patient was found to have chest tightness and shortness of breath with hyperlactatemia and was diagnosed mitochondrial myopathy with mtDNA 3243 A\u2009&gt;\u2009G mutation 11\u00a0months ago. Acute kidney injury occurred with hyperuricemia (urid acid 1011umol\/L) which may be associated with mtDNA mutation. Since then, persistent proteinuria was also found and the 24-h urine protein quantitative was around 2\u00a0g. Kidney biopsy was performed and the result was consistent with membranous nephropathy, with abnormal mitochondria seen in renal tubules by electron microscopy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with mitochondrial myopathy could also have renal presentation of membranous nephropathy. Patients with mtDNA mutation may have various renal manifestations so that more attention should be paid on their kidneys.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02710-0","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:02:49Z","timestamp":1646373769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case report of mitochondrial myopathy with membranous nephropathy"],"prefix":"10.1186","volume":"23","author":[{"given":"Minchao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"5","key":"2710_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrg1606","volume":"6","author":"RW Taylor","year":"2005","unstructured":"Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005;6(5):389\u2013402.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2710_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","volume":"15","author":"ST Ahmed","year":"2018","unstructured":"Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE. Diagnosis and Treatment of Mitochondrial Myopathies. Neurotherapeutics. 2018;15(4):943\u201353.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"2710_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1053\/j.ajkd.2016.06.027","volume":"68","author":"M Rudnicki","year":"2016","unstructured":"Rudnicki M, Mayr JA, Zschocke J, Antretter H, Regele H, Feichtinger RG, Windpessl M, Mayer G, Polzl G. MELAS Syndrome and Kidney Disease Without Fanconi Syndrome or Proteinuria: A Case Report. Am J Kidney Dis. 2016;68(6):949\u201353.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2710_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00467-011-1926-6","volume":"27","author":"F Emma","year":"2012","unstructured":"Emma F, Bertini E, Salviati L, Montini G. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol. 2012;27(4):539\u201350.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2710_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00415-009-5028-3","volume":"256","author":"S Di Donato","year":"2009","unstructured":"Di Donato S. Multisystem manifestations of mitochondrial disorders. J Neurol. 2009;256(5):693\u2013710.","journal-title":"J Neurol"},{"issue":"26","key":"2710_CR6","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656\u201368.","journal-title":"N Engl J Med"},{"issue":"8","key":"2710_CR7","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1097\/01.ASN.0000080180.51098.02","volume":"14","author":"B Guery","year":"2003","unstructured":"Guery B, Choukroun G, Noel LH, Clavel P, Rotig A, Lebon S, Rustin P, Bellane-Chantelot C, Mougenot B, Grunfeld JP, Chauveau D. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol. 2003;14(8):2099\u2013108.","journal-title":"J Am Soc Nephrol"},{"issue":"6 Pt 2","key":"2710_CR8","first-page":"F1608","volume":"258","author":"KG Dickman","year":"1990","unstructured":"Dickman KG, Mandel LJ. Differential effects of respiratory inhibitors on glycolysis in proximal tubules. Am J Physiol. 1990;258(6 Pt 2):F1608\u201315.","journal-title":"Am J Physiol"},{"issue":"2","key":"2710_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2169\/internalmedicine.41.113","volume":"41","author":"M Hirano","year":"2002","unstructured":"Hirano M, Konishi K, Arata N, Iyori M, Saruta T, Kuramochi S, Akizuki M. Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Intern Med. 2002;41(2):113\u20138.","journal-title":"Intern Med"},{"issue":"5","key":"2710_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3892\/br.2017.892","volume":"6","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Scorza FA. Renal manifestations of primary mitochondrial disorders. Biomed Rep. 2017;6(5):487\u201394.","journal-title":"Biomed Rep"},{"issue":"2","key":"2710_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajhg.2010.12.010","volume":"88","author":"R Belostotsky","year":"2011","unstructured":"Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S, Segel R, Elpeleg O, Nassar S, Frishberg Y. Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis. HUPRA syndrome Am J Hum Genet. 2011;88(2):193\u2013200.","journal-title":"HUPRA syndrome Am J Hum Genet"},{"key":"2710_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1476-511X-10-105","volume":"10","author":"T Kawamoto","year":"2011","unstructured":"Kawamoto T, Kokaze A, Ishikawa M, Matsunaga N, Karita K, Yoshida M, Shimada N, Ohtsu T, Shirasawa T, Ochiai H, Ito T, Hoshino H, Takashima Y. Joint effect of longevity-associated mitochondrial DNA 5178 C\/A polymorphism and alcohol consumption on risk of hyper-LDL cholesterolemia in middle-aged Japanese men. Lipids Health Dis. 2011;10:105.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"2710_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1046\/j.1523-1755.2001.0590041236.x","volume":"59","author":"O Hotta","year":"2001","unstructured":"Hotta O, Inoue CN, Miyabayashi S, Furuta T, Takeuchi A, Taguma Y. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int. 2001;59(4):1236\u201343.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02710-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02710-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:04:04Z","timestamp":1646373844000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02710-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2710"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02710-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this case presentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained for the publication of this case report from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}